An immunology expert says the bar will have to be "very high" for approving Covid vaccines for 5 to 11 year old's.
Pfizer says a trial has shown its jab is safe and effective for children that age. A significantly lower dosage was given than that administered to adults. European regulators and NIAC would need to approve extending the rollout to 5 to 11 year old's. Paul Moynagh, Professor of Immunology at Maynooth University, says any decision will need to be carefully considered. "Ultimately I think the bar has to be very, very high for children. "It's one of the positive things in terms that children are relatively resistant to a very mild disease. "We have to ask these questions surrounding the safety of the vaccine for children." Back to news Follow South East Radio on: Facebook – Instagram – Twitter – Linkedin